CLINICAL_TRIALS
trial_result
· 2011-05-17
Clinical Trial Update: A Study of Infliximab in Patients With Sarcoidosis [Phase 3]
Summary
The document notes the completion of a Phase 3 clinical trial evaluating infliximab in patients with sarcoidosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Sarcoidosis | Phase 3 | Status: COMPLETED